Applying the cut‐off values determined previously pathologic C1‐INH were found in 98.5% of the studied HAE I patients (66/67) and 100% of the patients with acquired C1‐inhibitory deficiency (10/10). This evidence concerns the gene SERPING1 and hereditary angioedema type 1.